Related Experiment Video
Updated: May 31, 2026
10:26
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Antithrombotic prophylaxis in the middle East.
Samir Arnaout1, Hanady R Samaha, Julien Succar
1American University of Beirut Medical Center, Beirut, Lebanon.
Summary
Venous thromboembolism (VTE) remains a global health issue due to underuse of anticoagulants and poor adherence to thromboprophylaxis guidelines. This review focuses on the Middle East and proposes strategies to combat rising VTE rates.
Area of Science:
- Medical Science
- Public Health
- Cardiology
Background:
- Venous thromboembolism (VTE) presents a significant global health challenge, marked by high incidence, morbidity, and mortality.
- Key contributing factors include the underutilization of anticoagulant therapies and inadequate adherence to established thromboprophylaxis guidelines.
- These issues represent growing global health concerns demanding urgent attention and intervention.
Purpose of the Study:
- To review the current landscape of venous thromboembolism incidence and contributing factors.
- To specifically examine the situation within the Middle East region.
- To propose actionable strategies for controlling the increasing prevalence of VTE.
Main Methods:
- Literature review of existing studies on VTE incidence and management.
- Analysis of factors contributing to underutilization of anticoagulants.
- Examination of adherence to thromboprophylaxis guidelines.
- Focus on regional data, particularly from the Middle East.
Main Results:
- High incidence of VTE persists globally, linked to suboptimal anticoagulant use.
- Failure to adhere to thromboprophylaxis guidelines is a critical and widespread problem.
- The Middle East region faces specific challenges related to VTE management.
Conclusions:
- Addressing the underutilization of anticoagulants is crucial for reducing VTE burden.
- Enhancing adherence to thromboprophylaxis guidelines is essential for effective prevention.
- Implementing targeted strategies is necessary to control the rising incidence of VTE, especially in regions like the Middle East.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...